Abstract:A majority of patients with SCD had sub-optimal SGC. The pharmacokinetic profile of such patients is apparently too variable to fit the existing Hartford protocol. The Hartford nomogram should be modified to address this issue. Otherwise, clinicians should revert to multiple daily dosing.
“…10 Our results demonstrate that the vancomycin-dosing requirement is increased by approximately 20% (0.043 vs. 0.036 gram/day/kg) in the HgbSS group to achieve a comparable drug level to HgbAA patients. Most of the vancomycin is excreted unchanged via glomerular filtration, 3 and glomerular hyperfiltration has caused increased vancomycin dosing requirements in other disease states.…”
“…10 Our results demonstrate that the vancomycin-dosing requirement is increased by approximately 20% (0.043 vs. 0.036 gram/day/kg) in the HgbSS group to achieve a comparable drug level to HgbAA patients. Most of the vancomycin is excreted unchanged via glomerular filtration, 3 and glomerular hyperfiltration has caused increased vancomycin dosing requirements in other disease states.…”
In addition to known covariates, ciprofloxacin clearance is greater in SCD children compared with non-SCD patients. The dosing of this agent needs to be adapted to this subgroup of patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.